Background Retinoblastoma is the most common intraocular cancer worldwide. There is
some evidence to suggest that major differences exist in treatment outcomes for children …

In the current era of global health awareness for retinoblastoma (RB), the challenge that lies
ahead of us is providing optimal care for children affected with RB in underdeveloped …

Purpose To describe the clinical presentation and treatment outcomes of children who
received a diagnosis of retinoblastoma in 2017 throughout Asia. Design Multinational …

Background Rates of care abandonment for retinoblastoma (RB) demonstrate significant
geographical variation; however, other variables that place a patient at risk of abandoning …

Purpose Globally, disparities exist in retinoblastoma treatment outcomes between high-and
low-income countries, but independent analysis of American countries is lacking. We report …

Background Solid evidence of the safety and effectiveness of retinoblastoma (RB)
conservative treatment using thermotherapy and systemic chemotherapy with long‐term …

The chemotherapy of retinoblastoma (RB), a malignant ocular childhood disease, is often
limited by the development of resistance against commonly used drugs. We identified …

Aim To define the prevalence of mortality and identify factors associated with mortality in
pediatric patients with extraocular retinoblastoma attending the tertiary hospital in Indonesia …

Background Studies on the clinical characteristics of retinoblastoma in Indonesia have been
limited, even though retinoblastoma is the most common pediatric ocular malignancy …

Retinoblastoma (RB) is the most common childhood intraocular malignancy. In high-income
countries over the past decade, upfront enucleation for unilateral RB is least favoured due to …